Scholar Rock Holding Corp (SRRK) director logs share buys and warrant exercise
Rhea-AI Filing Summary
Scholar Rock Holding Corp director Srinivas Akkaraju reported multiple transactions in the company’s common stock. On 10/07/2025, he indirectly purchased 12,796, 12,400 and 4,403 shares through Samsara Opportunity Fund, L.P. at weighted average prices of $39.31, $40.18 and $40.97 per share, increasing that fund’s indirect holdings to 530,038 shares.
On 12/12/2025, warrants with a $7.35 exercise price were exercised through Samsara BioCapital, L.P., resulting in the acquisition of 1,064,804 shares of common stock and raising that entity’s indirect holdings to 6,367,614 shares, with the related warrant position reduced to zero. The form also shows 21,132 shares of common stock held directly. Footnotes explain that the 10/07/2025 purchase prices are weighted averages for multiple trades within specified price ranges.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| X | Warrants to Purchase Common Stock | 1,064,804 | $0.00 | -- |
| X | Common Stock | 1,064,804 | $7.35 | $7.83M |
| Purchase | Common Stock | 12,796 | $39.31 | $503K |
| Purchase | Common Stock | 12,400 | $40.18 | $498K |
| Purchase | Common Stock | 4,403 | $40.97 | $180K |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $38.85 to $39.849 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities purchased at each separate price within the range set forth in this footnote. Securities are directly held by Samsara Opportunity Fund, L.P. ("Samsara Opportunity Fund"). Samsara Opportunity Fund GP, LLC ("Samsara Opportunity GP") is the general partner of Samsara Opportunity Fund and may be deemed to beneficially own the securities held by Samsara Opportunity Fund. The Reporting Person has voting and investment power over the securities held by Samsara Opportunity Fund and, accordingly, may be deemed to beneficially own the securities held by Samsara Opportunity Fund. The Reporting Person disclaims beneficial ownership in these securities except to the extent of his pecuniary interest therein. The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $39.8512 to $40.85 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities purchased at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $40.87 to $41.00 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities purchased at each separate price within the range set forth in this footnote. Securities are directly held by Samsara BioCapital LP ("Samsara LP"). Samsara BioCapital GP, LLC ("Samsara LLC") is the general partner of Samsara LP and may be deemed to beneficially own the securities held by Samsara LP. The Reporting Person has voting and investment power over the securities held by Samsara LP and, accordingly, may be deemed to beneficially own the securities held by Samsara LP. The Reporting Person disclaims beneficial ownership in these securities except to the extent of his pecuniary interest therein.
FAQ
What insider transactions did Scholar Rock (SRRK) disclose in this filing?
The filing shows that director Srinivas Akkaraju reported open-market purchases of Scholar Rock common stock on 10/07/2025 and the exercise of warrants on 12/12/2025, resulting in increased indirect and direct share ownership.
Does the filing explain how the reported Scholar Rock (SRRK) trade prices were calculated?
Yes. Footnotes state that the prices of $39.31, $40.18 and $40.97 reported for the 10/07/2025 purchases are weighted average prices from multiple trades within specified price ranges, and detailed per-trade data is available upon request.